EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alogliptin/Amentoflavone Combination Mitigates Bleomycin-Induced Lung Fibrosis: The Role of Oxidative Stress, TXNIP-Mediated Pyroptosis, and Autophagy/Apoptosis Balance

Hanan Abdelmawgoud Atia, Hemat A Elariny iD, Gehad M Subaiea iD, Asmaa Saleh iD, Amany M Khalifa iD, Doaa Hellal, Kareem M Younes, Ahmed M Kabel iD

Pharmaceuticals · 24.05.2026 · 19 (6) · 822

DOI: 10.3390/ph19060822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 24.05.2026. Verfasst von Hanan Abdelmawgoud Atia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, University of Ha'il, Ha'il 55473, Saudi Arabia. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ha'il University, Scientific Research Deanship at University of Ha’il, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Bleomycin is an antineoplastic antibiotic used in the management of various malignancies. Nevertheless, its benefits are constrained by the development of pulmonary fibrosis. Amentoflavone, a biflavonoid, exhibits diverse pharmacological activities, including anti-inflammatory, antiviral, antioxidant, and antitumor effects, whereas alogliptin possesses antioxidant and anti-inflammatory properties. This study aimed to assess the potential protective effects of alogliptin and/or amentoflavone in a murine model of bleomycin-induced pulmonary fibrosis and to clarify the underlying mechanisms.

Methods

Fifty male C57BL/6 mice were randomly divided into 5 equal groups: control, bleomycin, bleomycin + alogliptin, bleomycin + amentoflavone, and bleomycin + alogliptin + amentoflavone. The assessed endpoints included lung weight/body weight index, lung tissue fibrotic mediators, oxidative stress parameters, proinflammatory cytokines, and pyroptotic and autophagy mediators. Also, the bronchoalveolar lavage fluid (BALF) was evaluated for total and differential leukocytic counts and lactate dehydrogenase (LDH) activity. Moreover, vascular responses to potassium chloride, phenylephrine, and carbachol, together with tracheal responses to carbachol were determined. Lung tissues were further examined histopathologically and immunohistochemically.

Results

Treatment with alogliptin and/or amentoflavone significantly decreased the lung weight/body weight index and BALF LDH activity, concomitant with mitigation of lung tissue oxidative stress parameters, fibrotic mediators, apoptosis, and pyroptosis with a significant augmentation of autophagy signals, alongside marked improvement in the lung architecture and vascular and airway reactivity compared with the bleomycin group. These effects were most pronounced with animals treated with the alogliptin/amentoflavone combination.

Conclusions

These findings suggest that combined alogliptin and amentoflavone may constitute a promising strategy to prevent bleomycin-induced lung fibrosis.

Schlagwörter

Stichwörter der Autor:innen

alogliptinamentoflavonebleomycinlung fibrosismicepyroptosis

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, College of Pharmacy, University of Ha'il, Ha'il 55473, Saudi Arabia.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
  • Department of Pathology, College of Medicine, University of Ha'il, Ha'il 55473, Saudi Arabia.
  • Department of Pharmacology, College of Medicine, University of Ha'il, Ha'il 55473, Saudi Arabia.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, University of Ha'il, Ha'il 55473, Saudi Arabia.
  • Pharmacology Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.

ORCID-Profile: Hemat A Elariny, Gehad M Subaiea, Asmaa Saleh, Amany M Khalifa, Ahmed M Kabel

Förderung

  • Ha'il University
  • Scientific Research Deanship at University of Ha’il, Saudi Arabia

Zitieren

APA

Atia, H. A., Elariny, H. A., Subaiea, G. M., Saleh, A., Khalifa, A. M., Hellal, D., Younes, K. M., & Kabel, A. M. (2026). Alogliptin/Amentoflavone Combination Mitigates Bleomycin-Induced Lung Fibrosis: The Role of Oxidative Stress, TXNIP-Mediated Pyroptosis, and Autophagy/Apoptosis Balance. Pharmaceuticals, 19(6), 822. https://doi.org/10.3390/ph19060822

Vancouver

Atia HA, Elariny HA, Subaiea GM, Saleh A, Khalifa AM, Hellal D, et al. Alogliptin/Amentoflavone Combination Mitigates Bleomycin-Induced Lung Fibrosis: The Role of Oxidative Stress, TXNIP-Mediated Pyroptosis, and Autophagy/Apoptosis Balance. Pharmaceuticals. 2026;19(6):822. doi:10.3390/ph19060822

BibTeX
@article{Atia2026,
  author = {Atia, Hanan Abdelmawgoud and Elariny, Hemat A and Subaiea, Gehad M and Saleh, Asmaa and Khalifa, Amany M and Hellal, Doaa and Younes, Kareem M and Kabel, Ahmed M},
  title = {Alogliptin/Amentoflavone Combination Mitigates Bleomycin-Induced Lung Fibrosis: The Role of Oxidative Stress, TXNIP-Mediated Pyroptosis, and Autophagy/Apoptosis Balance},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {6},
  pages = {822},
  doi = {10.3390/ph19060822}
}
Kostenlos starten →